Investing.com - Ionis Pharma reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Ionis Pharma announced earnings per share of $-0.33 on revenue of $160M. Analysts polled by Investing.com anticipated EPS of $-0.72 on revenue of $145.75M.
Ionis Pharma shares are down 16.73% from the beginning of the year and are trading at $43.35 , down-from-52-week-high.
Ionis Pharma shares gained 2.60% in pre-market trade the report.
Ionis Pharma follows other major Healthcare sector earnings this month
Ionis Pharma's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.89B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar